DePuy Orthopaedics Recalls ASR Hip System

Caitlin LeValley and Laura Miller -   Print  |
Listen
Text
  • Small
  • Medium
  • Large
DePuy Orthopaedics has voluntarily recalled the ASR XL Acetabular System and DePuy ASR Hip Resurfacing System used in hip replacement surgery due to the number of patients who required a revision surgery, according to a DePuy news release.

The company posted a recall of the ASR 100 and 300 series Acetabular hip implant cups sizes 44mm to 70mm on the FDA website on July 17. The recall includes the ASR Hip Resurfacing system and the ASR XL Acetabular System.

DePuy Orthopaedics issued an Urgent Safety Notice to physicians in March warning of high revision rates in patients receiving the system and announced at that time the company would withdraw the implant from the market at the end of 2010. Reports of the metal-on-metal interface creating metal debris which caused inflammation of the surrounding tissue prompted the Notice.

The majority of ASR hip replacement surgeries have been successful, but DePuy is encouraging  patients with ASR devices to have their implant performance evaluated. DePuy is providing comprehensive recall information to hospitals, surgeons and patients to help them determine how to proceed, according to the release.

Read the DePuy release on the ASR hip resurfacing system recall.


Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Whitepapers

Featured Podcast